In a surprising turn of events, the newly appointed head of the U. S. drug regulatory agency has expressed serious doubts about the recent push to fast-track drug approvals. This official, who just started their role this month, believes that these changes might not only be against the law but could also put people's health in danger. The concern here is that the Tr...
The FDA has picked Dr. Richard Pazdur to head up its drug division. He's been with the agency for 26 years and is well-respected. This move comes after a rough patch for the FDA, with lots of staff leaving and morale taking a hit. Dr. Pazdur is known for approving many new cancer drugs. These drugs have helped patients and made a lot of money for the companies that ...
The U. S. Food and Drug Administration is looking to bring in a new boss for its drug approval team. This person, Richard Pazdur, is known for his work in cancer treatments. If he takes the job, he'll be in charge of making sure most medicines, from those you buy without a prescription to those needing a doctor's note, are safe and effective. This change comes after...
The world of drug and biologic product regulation is undergoing a significant shift. Generative artificial intelligence (AI) is at the heart of this change. It is making it easier and faster to find important information. This is not just about speed. It is about making the process of regulation more efficient and effective. The Food and Drug Administration (FDA) ha...